# Asston Pharma (NSE: APL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/APL · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹69 Cr, it ranks 2883rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Promoters held 50.66% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹69 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 50.66%
- Foreign institutions: 1.91%
- Non-institutions: 47.42%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Maestros Elect](https://app.pivotnow.in/stock/METSL) | — | ₹76 Cr | — | — |
| [Bharat Immuno](https://app.pivotnow.in/stock/BIBCL) | — | ₹75 Cr | — | — |
| [Source Natural](https://app.pivotnow.in/stock/SOURCENTRL) | — | ₹70 Cr | — | — |
| [Fervent Synergi](https://app.pivotnow.in/stock/FERVENTSYN) | — | ₹68 Cr | — | — |
| [Sunil Health](https://app.pivotnow.in/stock/SUNLOC) | ₹65.00 | ₹67 Cr | 16.6 | — |
| [Samrat Pharma](https://app.pivotnow.in/stock/SAMRATPH) | — | ₹61 Cr | — | — |

## Questions and answers

### What is the market cap of Asston Pharma?

Asston Pharma's market capitalisation is ₹69 Cr (₹69 Cr) at the 22 Oct 2026 close, ranking 2883rd among the NSE companies Pivot tracks.

### What is the shareholding pattern of Asston Pharma?

As of 31 Mar 2026: promoters 50.66%, foreign institutions 1.91%, non-institutions 47.42%.

### Who are Asston Pharma's competitors?

The listed Pharma & Healthcare companies closest to Asston Pharma by market cap are Maestros Elect, Bharat Immuno, Source Natural, Fervent Synergi, Sunil Health and Samrat Pharma.

### Is Asston Pharma a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Asston Pharma's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on APL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.